Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 5 | Molecular Autism

Fig. 5

From: Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations

Fig. 5

RMC-6272 reverses rapamycin-insensitive TSC1-associated alterations in mRNA translation. A, B Scatter plots (similar to Fig. 3A) of transcripts showing TSC1-associated mRNA translation that were reversed (A) or insensitive (B) to rapamycin treatment. The number of transcripts following each pattern of regulation is indicated. C, D Scatter plots of log2 fold changes from NanoString nCounter assays for transcripts showing TSC1-associated mRNA translation that was sensitive (C, left) or insensitive (D, left) to rapamycin (according to RNA sequencing-based quantification) but sensitive to RMC-6272 (C, D, right). Fold changes were calculated between cells treated with rapamycin (left) or RMC-6272 (right) relative to control (DMSO)

Back to article page

Molecular Autism

ISSN: 2040-2392